Treatment of ocular hypotony

Details Treatment of ocular hypotony Treatment of ocular hypotony

1996-07-01

1997-12-23

Fay, Zohreh

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514912, A61K 3156

Patent

active

057007942

ABSTRACT:
Methods for treating ocular hypotony are disclosed.

REFERENCES:
Starka, et al., Aldosterone: Its Occurrence, Metabolism and Binding in the Rabbit Eye, Exp. Eye Res., 25, 91-98 (1977).
Starka, et al., Aldosterone Binding in Bovine Ciliary Body, Endocrinologia Experimentalis, 11, 203-208 (1977).
Panigrahy, et al., Modulation of Intraocular Pressure by Aldosterone and Spironolactone, Investigative Ophthalmology & Visual Science, 35:4, 1388 (Mar. 15, 1994).
Frenkel, et al., Effects of Two Mineralocorticoids on Ocular Tension, Archives of Ophthalmology, 72, 315-318 (1964).
Marver, et al., Dihydrocortisol: A Potential Mineralocorticoid, Journal of Steroid Biochemistry, 9, 1-7 (1978).
Medline Abstract of Science (1983 Oct. 14) 222 (4620) 172-3. Weinstein et al.

Affiliated with

Also associated with

Rating

Treatment of ocular hypotony does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of ocular hypotony, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of ocular hypotony will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1802876